Investment with representation on Board of Directors, technical know-how transfer
Bangalore : Karkinos Healthcare, a technology-driven, oncology focussed managed health care platform, today announced that Mayo Clinic has invested a minority stake in the company, subject to certain conditions precedent. Mayo Clinic will also nominate a member on the Board of Directors of Karkinos as part of this agreement.
Karkinos Healthcare, which is pioneering the Distributed Cancer Care Network model in India has Ratan Tata, Venu Srinivasan, Kris Gopalakrishnan, Ronnie Screwvala, Vijay Shekar Sharma, and Bhavish Agarwal amongst its set of investors. The Tata Group is investing Rs. 110 crore in Karkinos while Rakuten Medical, the global clinical stage biotechnology company, and Reliance Digital Health, a subsidiary of Reliance Industries, hold minority stakes. Venture Capital fund Endiya Partners also has a stake in the company.
Karkinos is pioneering the Distributed Cancer Care Network model in India addressing clinical needs of cancer patients. The company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing care closer to patients backed by a robust technology platform. Karkinos already offers its services in Kothamangalam, Chottanikkara, Thodupuzha, Munnar locations across Ernakulum and Idukki Districts, in Kerala and is planning to ramp up its operations across India. The company is also setting up a Cancer Centre in Jawaharlal Nehru Institute of Medical Sciences (JNIMS) premises at Imphal, in partnership with Government of Manipur.